No Oral Contraceptive Pill Causes Clinically Significant Weight Gain
The evidence clearly shows that combined oral contraceptives (COCs) do not cause weight gain in the vast majority of users—this is a widespread misconception not supported by high-quality data. 1
The Evidence on Weight and Birth Control Pills
Combined Oral Contraceptives Are Weight-Neutral
The French Society of Endocrinology guidelines explicitly state that "at the population scale, there is no evidence that estrogen–progestin contraception causes weight gain" 1. This finding is reinforced by:
- Placebo-controlled trials showing no causal association between COCs and weight gain 2
- A large study of 1,971 women using 20 μg ethinylestradiol/75 μg gestodene showed mean weight change of less than 0.3 kg after 12 cycles, with 70% of women experiencing changes of ±2 kg or less 3
- Daily weight measurements in 128 women over 4 cycles showed zero average weight change, with 72% having either no change or weight loss 4
If You Must Choose: Drospirenone-Containing Pills May Have a Slight Edge
While most COCs are weight-neutral, one head-to-head trial found that 30 μg ethinylestradiol/3 mg drospirenone (EE/DRSP) was associated with slight weight loss (-0.20 kg at 6 months) compared to 30 μg ethinylestradiol/2 mg chlormadinone acetate (EE/CMA), which showed weight gain (+1.00 kg) 5. The difference was statistically significant but clinically modest.
Drospirenone-containing pills may theoretically reduce fluid retention due to drospirenone's anti-mineralocorticoid properties, which could explain this small advantage.
Low-Dose Formulations Are Also Weight-Neutral
Pills containing 20 μg ethinylestradiol with gestodene showed no clinically relevant weight changes and did not affect body composition measured by bioelectrical impedance 3, 6. These lower-dose formulations are equally appropriate choices.
What About Progestin-Only Pills?
The guidelines note that progestin-only pills (POPs) can be used without restriction in various populations, including obese women 1. However, the evidence provided does not specifically compare weight effects between different oral contraceptive formulations and POPs.
Important caveat: Injectable DMPA (depot medroxyprogesterone acetate) is NOT a pill but is noted to cause weight gain, particularly in obese adolescents 1. This should not be confused with oral contraceptives.
Clinical Bottom Line
Counsel patients that weight gain from birth control pills is largely a myth. Any perceived weight changes are typically due to:
- Normal cyclic fluid fluctuations (approximately 0.5 lb during the menstrual cycle) 4
- Natural age-related weight trajectories misattributed to the pill 7
- Nocebo effect from expecting weight gain 7
If a patient is particularly concerned about weight, consider prescribing:
- First choice: A drospirenone-containing COC (e.g., 30 μg EE/3 mg DRSP)
- Alternative: Any low-dose COC (20 μg ethinylestradiol formulations)
- Reassure that 52-72% of women remain within 2 pounds of baseline weight 4
The key is addressing the misconception directly, as fear of weight gain is a major barrier to effective contraception and leads to unnecessary discontinuation 2, 7.